Table 2 Univariate and multivariate regression analysis for comparison of EVF by clinical outcome

Unfavorable outcome

164(53.42%)

57(76.00%)

107(46.12%)

 Univariate analysis

3.69(2.05–6.99)

< 0.001

2.35(1.25–4.40)

0.008

 Model 1

2.96(1.53–5.71)

0.001

2.88(1.49–5.59)

0.002

 Model 2

2.69(1.37–5.26)

0.004

2.70(1.39–5.25)

0.003

MBE

59(19.21%)

28(37.33%)

31(13.36%)

 Univariate analysis

3.86(2.11–7.04)

< 0.001

2.52(1.33–4.76)

0.004

 Model 1

3.16(1.62–6.18)

0.001

3.02(1.56–5.84)

0.001

 Model 2

3.06(1.56–6.01)

0.001

3.01(1.55–5.84)

0.001

SICH

31(10.10%)

16(21.33%)

15(6.47%)

 Univariate analysis

3.92(1.83–8.39)

< 0.001

2.59(1.15–5.79)

0.021

 Model 1

3.42(1.51–7.74)

0.003

3.14(1.37–7.16)

0.006

 Model 2

3.24(1.42–7.37)

0.005

3.25(1.38–7.62)

0.007

HT

107(34.85%)

43(57.33%)

64(27.59%)

 Univariate analysis

3.52(2.05–6.05)

< 0.001

2.73(1.53–4.84)

0.001

 Model 1

3.06(1.72–5.46)

< 0.001

2.94(1.64–5.29)

< 0.001

 Model 2

3.11(1.73–5.62)

< 0.001

3.26(1.81–5.88)

< 0.001